{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:17:00Z","timestamp":1700284620859},"reference-count":43,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T00:00:00Z","timestamp":1124668800000},"content-version":"vor","delay-in-days":1056,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p>To enhance the efficacy of suicide gene therapy for prostate cancer under androgen deprivation, we designed a promoter system that consists of the prostate\u2010specific membrane antigen (PSMA) promoter\/enhancer (PEPM) and Cre\u2010loxP DNA recombination system. We constructed two kinds of plasmids. One plasmid contains a Cre recombinase (Cre) under the control of PEPM and the other expresses CMV\u2010lox\u2010luciferase\/herpes simplex virus thymidine kinase (TK). In PSMA\u2010positive LNCaP cells, the promoter activity of the PEPM\u2010Cre plus CMV\u2010lox\u2010luciferase demonstrated 800\u2010fold greater activity compared with that of the PSMA promoter alone. However, no enhancement of the promoter activity was observed in the PSMA\u2010negative cells. Furthermore, in contrast to prostate specific antigen promoter\/enhancer (PP), the promoter activity of PEPM did not decrease when the LNCaP cells were cultured in charcoal\u2010stripped fetal bovine serum (CFBS). In an <jats:italic>in vitro<\/jats:italic> gene therapy model with LNCaP cells, the cell growth inhibition in the presence of ganciclovir (GCV) was more evident in the cells transfected with the PEPM\u2010Cre plus CMV\u2010lox\u2010TK than in the cells with the PP\u2010TK, and the difference in efficacy between the two plasmids was more remarkable when the cells were maintained in CFBS medium. The therapeutic effect of PEPM\u2010Cre plus CMV\u2010lox\u2010TK was also observed in xenografted LNCaP cells on nude mice when the plasmids were directly injected into tumors and GCV was administered intraperitoneally. These findings indicate that the combination of the PSMA promoter\/enhancer and the Cre\u2010loxP system can enhance the PSMA promoter activity even under androgen ablation conditions and can exert its anti\u2010tumor effect both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1349-7006.2002.tb01218.x","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T10:39:13Z","timestamp":1124707153000},"page":"1154-1163","source":"Crossref","is-referenced-by-count":13,"title":["Development of Gene Therapy Using Prostate\u2010specific Membrane Antigen Promoter\/Enhancer with Cre Recombinase\/LoxP System for Prostate Cancer Cells under Androgen Ablation Condition"],"prefix":"10.1111","volume":"93","author":[{"given":"Shusei","family":"Ikegami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Tadakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)63094-5"},{"key":"e_1_2_1_3_2","first-page":"334","article-title":"Prostate\u2010specific antigen promoter\/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue\u2010specific adenovirus vector","volume":"60","author":"Latham J. P. F.","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_1_4_2","first-page":"495","article-title":"Identification of a positive regulatory element responsible for tissue\u2010specific expression of prostate\u2010specific antigen","volume":"57","author":"Pang S.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_1_5_2","first-page":"1276","article-title":"Coexpression of the partial androgen receptor enhances the efficacy of prostate\u2010specific antigen promoter\u2010driven suicide gene therapy for prostate cancer cells at low testosterone concentrations","volume":"61","author":"Suzuki S.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_1_6_2","first-page":"227","article-title":"Molecular cloning of a complementary DNA encoding a prostate\u2010specific membrane antigen","volume":"53","author":"Israeli R. S.","year":"1993","journal-title":"Cancer Res."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S"},{"key":"e_1_2_1_8_2","first-page":"1807","article-title":"Expression of the prostate\u2010specific membrane antigen","volume":"54","author":"Israeli R. S.","year":"1994","journal-title":"Cancer Res."},{"key":"e_1_2_1_9_2","first-page":"81","article-title":"Prostate\u2010specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver D. A.","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/1078-1439(95)00002-Y"},{"key":"e_1_2_1_11_2","first-page":"2674","article-title":"Prostate\u2010specific membrane antigen is produced in tumor\u2010associated neovas\u2010culature","volume":"5","author":"Chang S. S.","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_1_12_2","first-page":"2321","article-title":"Enhanced expression of prostate\u2010specific membrane antigen gene in prostate cancer as revealed by in situ hybridization","volume":"57","author":"Kawasaki M.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00184-7"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(81)90375-2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.8087"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050991"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4781(98)00200-0"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0045(20001001)45:2<149::AID-PROS9>3.0.CO;2-O"},{"key":"e_1_2_1_19_2","first-page":"38","article-title":"Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium","volume":"2","author":"Logan J. J.","year":"1995","journal-title":"Gene Ther."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2000.tb00951.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.2-223"},{"key":"e_1_2_1_22_2","first-page":"8","article-title":"Systemic tumor suppression by proapoptotic gene bik","volume":"62","author":"Zou Y.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_1_23_2","first-page":"3753","article-title":"Acceleration of human prostate carcinoma growth in vivo by factors produced by prostate and bone fibroblasts","volume":"51","author":"Gleave M.","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<395::AID-JCB8>3.0.CO;2-0"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01256-0"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199906)179:3<336::AID-JCP11>3.0.CO;2-Q"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700004"},{"key":"e_1_2_1_28_2","first-page":"382","article-title":"Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase\u20107 as a new gene therapy strategy for prostate cancer","volume":"59","author":"Marcelli M.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_1_29_2","first-page":"2075","article-title":"Relative efficiency of tumor cell killing in vitro by two enzyme\u2010prodrug systems delivered by identical adenovirus vectors","volume":"3","author":"Lockett L. J.","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300728"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700086"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300353"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/43977"},{"key":"e_1_2_1_34_2","first-page":"2697","article-title":"Herpes simplex virus thymidine kinase\/ganciclovir\u2010mediated apoptotic death of bystander cells","volume":"56","author":"Hamel W.","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.5.1831"},{"key":"e_1_2_1_36_2","first-page":"2681","article-title":"Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer","volume":"57","author":"Nomura T.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.17.8302"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00362.x"},{"key":"e_1_2_1_39_2","first-page":"3192","article-title":"Five different antiprostate\u2010specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor\u2010associated neovasculature","volume":"59","author":"Chang S. S.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_1_40_2","first-page":"4787","article-title":"Identification, purification, and subcellular localization of prostate\u2010specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line","volume":"58","author":"Grauer L. S.","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62198-0"},{"key":"e_1_2_1_42_2","first-page":"5237","article-title":"In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate\u2010specific membrane antigen","volume":"60","author":"Smith\u2010Jones P. M.","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_1_43_2","first-page":"2008","article-title":"Response of LNCaP spheroids after treatment with an \u03b1\u2010particle emitter (213Bi)\u2010labeled anti\u2010prostate\u2010specific membrane antigen antibody (J591)","volume":"61","author":"Ballangrud \u00c5. M.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_1_44_2","first-page":"6095","article-title":"An \u03b1\u2010particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer","volume":"60","author":"Mcdevitt M. R.","year":"2000","journal-title":"Cancer Res."}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2002.tb01218.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2002.tb01218.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:09:08Z","timestamp":1700266148000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2002.tb01218.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1111\/j.1349-7006.2002.tb01218.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01218.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}